The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...

Strengthens the Novartis oncology pipeline with two lead ADC assets and a broader payload platform with potential impact ...

Introducing Claude Science, the AI platform designed to expedite the discovery of promising new therapies. Anthropic will ...

Anthropic also went a step further, saying it would develop drugs of its own. Head of life sciences Eric Kauderer-Abrams said ...

Also served as the Representative Director and General Manager of Labcorp Laboratories Japan and Chief Executive Officer (CEO) of the Global Health Innovative Technology (GHIT) Fund, driving ...

Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext®, Labcorp’s non-invasive blood-based diagnostic test powered ...

Vertex Pharmaceuticals and CRISPR Therapeutics' gene-editing drug is the only sickle cell disease gene therapy on the market for young children.

Detailed price information for Laboratory Corp of America (LH-N) from The Globe and Mail including charting and trades.

DelveInsight's Oncology-Based In-Vivo CRO Market Insights report provides the current and forecast market analysis, ...

A team of researchers at the University of Warwick and Monash University has solved a puzzle that has stumped drug developers ...

AI giant Anthropic has already become a dominant player in technology and a household name for everyday users of artificial ...

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on ...